Shakir Sarwar is an Oncology physician affiliated with Grant Medical Center. OpenAlex indexes 5 publications with 423 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
- PFIZER INC.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
52.2%Kinase inhibitor16.3%Verzenio24%Tasigna22%Imatinib Mesylate17%Ibrance15%Brukinsa7%Imbruvica7%Tagrisso7%Part D<11 patientsAromatase Inhibitor11.2%Anastrozole78%Letrozole22%Part D<11 patients+ 8 more classes in this area
Metabolism & gastrointestinal
14.6%Serotonin-3 Receptor Antagonist6.9%Ondansetron Hcl80%Ondansetron Odt20%Part D<11 patientsCorticosteroid4.9%Prednisone100%Part D≥18 patients+ 1 more class in this area
Nervous system
12.2%Phenothiazine6.3%Prochlorperazine Maleate100%Part D≥47 patientsGabapentinoids3.3%Gabapentin100%Part D≥13 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Burkitt’s lymphoma presenting as multiple nerve sheath tumors of the cauda equina
Surgical Neurology International
2025 - Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41
Breast Cancer Research and Treatment
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”